Together, through this project, Bio-Rad and AHN aim to generate clinical evidence to support the use of Bio-Rad’s Droplet Digital PCR Systems, including the QX600™ ddPCR System, in routine MRD ...
The QX600™ Droplet Digital™ PCR System enables advanced six-color multiplexing, allowing clear discrimination of multiple targets with our extensive library of pre-optimized assays. The QX600 System ...
Bio-Rad Laboratories, Inc.’s BIO solid momentum in the QX600 Droplet Digital PCR (ddPCR) platform is poised to help it grow in the upcoming quarters. The clinical diagnostics business sees ...
The QX600 Droplet Reader enables six-color detection for multiplexing, allowing the clear discrimination of multiple targets with assays that can port over and grow from the QX200 Droplet DigitalTM ...
Zacks.com on MSN29 天
Why Bio-Rad Stock is an Apt Pick for Your Portfolio Right NowThe renowned manufacturer and global supplier of clinical diagnostics and life science research products has a market capitalization of $9.57 billion. Bio-Rad’s earnings surpassed estimates in each of ...
Edward Chung; Vice President - Investor Relations; Bio Rad Laboratories Inc. Unidentified Company Representative. Roop Lakkaraju; Chief Financial Officer, Executive ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果